Filing Flows › Clover Health Investments (CLOV) › Q2 2026 › vs Q1 2026
Clover Health Investments (CLOV) Q2 2026 vs Q1 2026 (quarter over quarter)
Clover Health Investments's revenue fell $6.0M (-0.8%) from $749M in Q1 2026 to $743M in Q2 2026. Operating margin 3.8% against 3.6% (+0.1 pts).
Clover Health Investments, Q2 2026: revenue $743M (+56% year over year), operating margin 3.8%, net earnings $28.0M, operating cash flow $25.2M. The chart draws each line against Q1 2026, the increases inside each band.
Margins
| Q2 2026 | Q1 2026 | Change | |
|---|---|---|---|
| Operating margin | 3.8% | 3.6% | +0.1 pts |
| Net margin | 3.8% | 3.6% | +0.1 pts |
| Free cash flow margin | 3.3% | 14.3% | -11.0 pts |
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $743M | $749M | −$6.0M | -0.8% |
| Operating profit | $28.0M | $27.3M | $667K | +2% |
| Costs & expenses | $715M | $722M | −$6.7M | -0.9% |
| Pre-tax earnings | $28.0M | $27.3M | $667K | +2% |
| General & admin | $70.3M | $74.6M | −$4.3M | -6% |
| Other operating costs | $645M | $647M | −$2.4M | -0.4% |
| Net earnings | $28.0M | $27.3M | $667K | +2% |
| Share-based compensation | $9.1M | $12.3M | −$3.2M | -26% |
| Working capital & other | $11.9M | −$68.3M | $80.2M | — |
| Operating cash flow | $25.2M | $108M | −$82.7M | -77% |
| Free cash flow (OCF − capex) | $24.5M | $107M | −$82.5M | -77% |
| Capital expenditures | $682K | $854K | −$172K | -20% |
Questions
How much did Clover Health Investments's revenue grow quarter over quarter in Q2 2026?
Clover Health Investments's revenue fell $6.0M (-0.8%) from $749M in Q1 2026 to $743M in Q2 2026. Operating margin 3.8% against 3.6% (+0.1 pts).